What are the regulatory challenges in approving novel insulin therapies, and how do they impact the availability of advanced treatments for diabetic patients worldwide?
Sunil JoshiExplorer
What are the regulatory challenges in approving novel insulin therapies?
Share
Regulatory hurdles for novel insulin therapies include rigorous efficacy and safety testing, and long approval processes, which can delay market entry and limit global access to advanced diabetic treatments.